Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AMAG Appoints Quality VP | Contract Pharma
Promotions & Moves

AMAG Appoints Quality VP

Sanchez has more than 25 years of experience in the pharmaceutical and medical device industries

Oscar Sanchez has been appointed vice president of quality, AMAG Pharmaceuticals. He reports to Joseph Vittiglio, general counsel and senior vice president of legal affairs and quality.

Mr. Sanchez is responsible for creating and implementing programs, policies and procedures related to quality assurance and quality control activities across the company’s commercially-available therapeutics, multiple development stage products and cord blood banking services. He will also provide compliance oversight of activities involving recognized quality standards, such as good manufacturing practices and good clinical practices, as well as accreditations and industry certifications.

“Oscar brings a wealth of experience to AMAG, having led the quality function at various global pharmaceutical organizations,” said Mr. Vittiglio. “His quality and regulatory experience will be essential to our business as AMAG continues to develop and market novel therapeutics to address significant unmet medical needs.”

Mr. Sanchez has more than 25 years of experience in the pharmaceutical and medical device industries, serving in leadership roles at organizations such as Albany Molecular Research Institute, MAQUET, Novartis and General Electric Healthcare, among others.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters